Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS IN UNCONSOLIDATED ENTITIES - Summary of Condensed Financial Information Related to Unconsolidated Equity Method Joint Ventures, Assets Liabilities and Equity (Details)

v3.22.2.2
INVESTMENTS IN UNCONSOLIDATED ENTITIES - Summary of Condensed Financial Information Related to Unconsolidated Equity Method Joint Ventures, Assets Liabilities and Equity (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Assets                    
Real estate $ 4,726,262   $ 4,726,262       $ 3,734,408      
Other assets 745,044   745,044       976,682      
Total assets 5,571,090   5,571,090       4,807,533      
Equity of:                    
Meritage 3,681,810 $ 2,825,270 3,681,810 $ 2,825,270 $ 3,412,469 $ 3,168,315 3,044,389 $ 2,628,144 $ 2,476,693 $ 2,347,868
Total liabilities and stockholders’ equity 5,571,090   5,571,090       4,807,533      
Earnings from financial services unconsolidated entities and other, net     3,703 2,878            
Unconsolidated entities                    
Equity of:                    
Earnings from financial services unconsolidated entities and other, net 2,548 $ 1,899 5,418 $ 4,473            
Equity Method Investment, Nonconsolidated Investee                    
Assets                    
Real estate 17,628   17,628       7,989      
Other assets 7,844   7,844       3,903      
Total assets 28,240   28,240       19,875      
Liabilities and equity:                    
Accounts payable and other liabilities 6,870   6,870       7,899      
Equity of:                    
Meritage [1] 10,195   10,195       4,752      
Other 11,175   11,175       7,224      
Total liabilities and stockholders’ equity 28,240   28,240       19,875      
Cash 2,768   2,768       7,983      
Cash $ 2,768   $ 2,768       $ 7,983      
[1] Balance represents Meritage’s interest, as reflected in the financial records of the respective joint ventures. This balance may differ from the balance reported in the accompanying unaudited consolidated financial statements due to the following reconciling items: (i) timing differences for revenue and distributions recognition, (ii) step-up basis and corresponding amortization, (iii) capitalization of interest on qualified assets, (iv) income deferrals as discussed in Note (2) below and (v) the cessation of allocation of losses from joint ventures in which we have previously written down our investment balance to zero and where we have no commitment to fund additional losses.